{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:18:03Z","timestamp":1787761083056,"version":"build-2784847793"},"update-to":[{"DOI":"10.1016\/j.cell.2020.03.051","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000}}],"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":394,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006154","name":"Lauri Strauss Leukemia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.cell.2020.03.051","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T11:05:02Z","timestamp":1587380702000},"page":"702-715.e20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["RETRACTED: Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2"],"prefix":"10.1016","volume":"181","author":[{"given":"Ken","family":"Morita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuning","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rados\u0142aw P.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"Durbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan W.","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Prutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael S.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Thomas","family":"Look","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2020.03.051_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ab.2008.10.044","article-title":"A set of baculovirus transfer vectors for screening of affinity tags and parallel expression strategies","volume":"385","author":"Abdulrahman","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cell.2020.03.051_bib40","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI79743","article-title":"A versatile modular vector system for rapid combinatorial mammalian genetics","volume":"125","author":"Albers","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cell.2020.03.051_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/jpet.106.116384","article-title":"Identification of amino acid determinants of dopamine 2 receptor synthetic agonist function","volume":"321","author":"Al-Fulaij","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cell.2020.03.051_bib3","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1172\/JCI45557","article-title":"Preclinical assessment of CNS drug action using eye movements in mice","volume":"121","author":"Cahill","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cell.2020.03.051_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.cell.2020.03.051_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/363274a0","article-title":"Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha","volume":"363","author":"Conklin","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.cell.2020.03.051_bib6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-05-501072","article-title":"Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile","volume":"122","author":"Cramer-Morales","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cell.2020.03.051_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0006-8993(98)01258-X","article-title":"Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests","volume":"835","author":"Crawley","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.cell.2020.03.051_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1083\/jcb.201606033","article-title":"A PP2A-B55 recognition signal controls substrate dephosphorylation kinetics during mitotic exit","volume":"214","author":"Cundell","year":"2016","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.cell.2020.03.051_bib9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1172\/JCI65093","article-title":"Phenothiazines induce PP2A-mediated apoptosis in T\u00a0cell acute lymphoblastic leukemia","volume":"124","author":"Gutierrez","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cell.2020.03.051_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0014-2999(86)90793-4","article-title":"Phenothiazine drug metabolites: dopamine D2 receptor, alpha 1- and alpha 2-adrenoceptor binding","volume":"125","author":"Hals","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cell.2020.03.051_bib11","doi-asserted-by":"crossref","first-page":"e00825","DOI":"10.7554\/eLife.00825","article-title":"MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy","volume":"2","author":"Heinrichs","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.cell.2020.03.051_bib12","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.molcel.2016.06.024","article-title":"A conserved motif provides binding specificity to the PP2A-B56 phosphatase","volume":"63","author":"Hertz","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2020.03.051_bib13","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1038\/sj.onc.1203937","article-title":"An alternatively spliced isoform of B-Myb is a transcriptional inhibitor","volume":"19","author":"Horstmann","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2020.03.051_bib14","doi-asserted-by":"crossref","first-page":"21008","DOI":"10.1074\/jbc.M116.739920","article-title":"Leucine carboxyl methyltransferase 1 (LCMT-1) methylates protein phosphatase 4 (PP4) and protein phosphatase 6 (PP6) and differentially regulates the stable formation of different PP4 holoenzymes","volume":"291","author":"Hwang","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2020.03.051_bib41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1091\/mbc.e03-05-0293","article-title":"Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors","volume":"15","author":"Jeanneteau","year":"2004","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.cell.2020.03.051_bib42","doi-asserted-by":"crossref","first-page":"36741","DOI":"10.1074\/jbc.274.51.36741","article-title":"Phosphorylation of B-Myb regulates its transactivation potential and DNA binding","volume":"274","author":"Johnson","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cell.2020.03.051_bib15","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1016\/j.bmc.2015.07.007","article-title":"Reengineered tricyclic anti-cancer agents","volume":"23","author":"Kastrinsky","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cell.2020.03.051_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaq1093","article-title":"PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells","volume":"10","author":"Kauko","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2020.03.051_bib17","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1042\/BST20160161","article-title":"Regulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1","volume":"44","author":"Kaur","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.cell.2020.03.051_bib18","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.1074\/jbc.M311484200","article-title":"Structure of protein phosphatase methyltransferase 1 (PPM1), a leucine carboxyl methyltransferase involved in the regulation of protein phosphatase 2A activity","volume":"279","author":"Leulliot","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2020.03.051_bib19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41375-018-0201-2","article-title":"The MCL1-specific inhibitor S63845 acts synergistically with venetoclax\/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells","volume":"33","author":"Li","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.cell.2020.03.051_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.vascn.2011.03.003","article-title":"Comparison of methods for the assessment of locomotor activity in rodent safety pharmacology studies","volume":"64","author":"Lynch","year":"2011","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.cell.2020.03.051_bib21","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1158\/0008-5472.CAN-17-0123","article-title":"Small-molecule activators of protein phosphatase 2A for the treatment of castration-resistant prostate cancer","volume":"78","author":"McClinch","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2020.03.051_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.devcel.2017.01.012","article-title":"Large-scale analysis of CRISPR\/cas9 cell-cycle knockouts reveals the diversity of p53-dependent responses to cell-cycle defects","volume":"40","author":"McKinley","year":"2017","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cell.2020.03.051_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/157015909790031229","article-title":"Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I","volume":"7","author":"Miller","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.cell.2020.03.051_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/157015909790031184","article-title":"Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II","volume":"7","author":"Miller","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.cell.2020.03.051_bib25","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/leu.2015.137","article-title":"BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4","volume":"29","author":"Morita","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.cell.2020.03.051_bib26","doi-asserted-by":"crossref","first-page":"e2895","DOI":"10.1038\/cddis.2017.244","article-title":"MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis","volume":"8","author":"Musa","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cell.2020.03.051_bib27","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1021\/jm200436t","article-title":"N-benzoylated phenoxazines and phenothiazines: synthesis, antiproliferative activity, and inhibition of tubulin polymerization","volume":"54","author":"Prinz","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.cell.2020.03.051_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/acs.jmedchem.6b01591","article-title":"N-Heterocyclic (4-phenylpiperazin-1-yl)methanones derived from phenoxazine and phenothiazine as highly potent inhibitors of tubulin polymerization","volume":"60","author":"Prinz","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.cell.2020.03.051_bib43","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cell.2020.03.051_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbacli.2016.08.002","article-title":"The broken \u201cOff\u201d switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance","volume":"6","author":"Ruvolo","year":"2016","journal-title":"BBA Clin."},{"key":"10.1016\/j.cell.2020.03.051_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc3556","article-title":"The DREAM complex: master coordinator of cell cycle-dependent gene expression","volume":"13","author":"Sadasivam","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2020.03.051_bib31","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/jac\/dku036","article-title":"Novel non-neuroleptic phenothiazines inhibit Mycobacterium tuberculosis replication","volume":"69","author":"Salie","year":"2014","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.cell.2020.03.051_bib32","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/febs.13573","article-title":"All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase","volume":"283","author":"Sangodkar","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.cell.2020.03.051_bib33","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1172\/JCI89548","article-title":"Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth","volume":"127","author":"Sangodkar","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cell.2020.03.051_bib44","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.cell.2020.03.051_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3371\/CSRP.4.1.5","article-title":"Dopamine D2 receptors as treatment targets in schizophrenia","volume":"4","author":"Seeman","year":"2010","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.cell.2020.03.051_bib35","doi-asserted-by":"crossref","first-page":"27396","DOI":"10.1074\/jbc.M113.490102","article-title":"Leucine carboxyl methyltransferase 1 (LCMT1)-dependent methylation regulates the association of protein phosphatase 2A and Tau protein with plasma membrane microdomains in neuroblastoma cells","volume":"288","author":"Sontag","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2020.03.051_bib36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2010.12.030","article-title":"The structural basis for tight control of PP2A methylation and function by LCMT-1","volume":"41","author":"Stanevich","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2020.03.051_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1107\/S0907444910042204","article-title":"The structure of human leucine carboxyl methyltransferase 1 that regulates protein phosphatase PP2A","volume":"67","author":"Tsai","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cell.2020.03.051_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/nar\/gky935","article-title":"Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis\/trans isomerization","volume":"47","author":"Werwein","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2020.03.051_bib39","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1111\/febs.14617","article-title":"Targeted therapies don\u2019t work for a reason; the neglected tumor suppressor phosphatase PP2A strikes back","volume":"285","author":"Westermarck","year":"2018","journal-title":"FEBS J."}],"updated-by":[{"DOI":"10.1016\/j.cell.2022.07.008","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"record-id":"38498"},{"DOI":"10.1016\/j.cell.2022.07.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000}},{"DOI":"10.1016\/j.cell.2020.03.051","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000}}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867420303445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867420303445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:44:48Z","timestamp":1758800688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867420303445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0092867420303445"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2020.03.051","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737780631.793577330","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.737780631.793577218","asserted-by":"object"}]},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2020.03.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}